Risk Factors for Relapse and Higher Costs among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History

Clinical trials show that opioid agonist therapy (OAT) with methadone or buprenorphine is more effective than behavioral treatments, but state policymakers remain ambivalent about covering OAT for long periods. We used Medicaid claims for 52,278 Massachusetts Medicaid beneficiaries with a diagnosis...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Subst Abuse Treat
Hlavní autoři: Clark, Robin E., Baxter, Jeffrey D., Aweh, Gideon, O'Connell, Elizabeth, Fisher, William H., Barton, Bruce A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4560989/
https://ncbi.nlm.nih.gov/pubmed/25997674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2015.05.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky